Ventricular tachycardia

• Alternative Names

  Wide-complex tachycardia; V tach; Tachycardia - ventricular

• Causes, incidence, and risk factors

  Ventricular tachycardia is a pulse rate of more than 100 beats per minute, with at least 3 irregular heartbeats in a row.

  The condition can develop as an early or late complication of a heart attack. It may also occur in patients with:

  • Cardiomyopathy
  • Heart failure
  • Heart surgery
  • Myocarditis
  • Valvular heart disease

  Ventricular tachycardia can occur without heart disease.

  Scar tissue may form in the muscle of the ventricles days, months, or years after a heart attack. This can lead to ventricular tachycardia.

  Ventricular tachycardia can also be caused by:

  • Anti-arrhythmic medications
  • Changes in blood chemistry (such as a low potassium level)
  • Changes in pH (acid-base)
  • Lack of enough oxygen

  "Torsade de pointes" is a form of ventricular tachycardia that is often due to congenital heart disease or the use of certain medications.

• Symptoms

  If the heart rate during a ventricular tachycardia episode is very fast or lasts longer than a few seconds, there may be symptoms such as:

  • Chest discomfort (angina)
  • Fainting (syncope)
  • Light-headedness or dizziness
  • Sensation of feeling the heart beat (palpitations)
  • Shortness of breath

  Note: Symptoms may start and stop suddenly. In some cases, there are no symptoms.

• Signs and tests

  Signs include:

  • Absent pulse
  • Loss of consciousness
  • Normal or low blood pressure
  • Rapid pulse

  Ventricular tachycardia may be seen on:

  • Continuous ambulatory electrocardiogram (Holter monitor)
  • ECG
  • Intracardiac electrophysiology study (EPS)
  • Loop recorder

  Blood chemistries and other tests may be done.

• Treatment

  Treatment depends on the symptoms, and the type of heart disorder. Some people may not need treatment.

  If ventricular tachycardia becomes an emergency situation, it may require:

  • CPR
  • Electrical defibrillation or cardioversion (electric shock)
  • Anti-arrhythmic medications (such as lidocaine, procainamide, sotalol, or amiodarone) given through a vein

  Long-term treatment of ventricular tachycardia may require the use of oral anti-arrhythmic medications (such as procainamide, amiodarone, or sotalol). However, anti-arrhythmic medications may have severe side effects. Their use is decreasing in favor of other treatments.

  Some ventricular tachycardias may be treated with an ablation procedure. Radiofrequency catheter ablation can cure certain tachycardias.

  A preferred treatment for many chronic (long-term) ventricular tachycardias consists of implanting a device called implantable cardioverter defibrillator (ICD). The ICD is usually implanted in the chest, like a pacemaker. It is connected to the heart with wires.

  The doctor programs the ICD to sense when ventricular tachycardia is occurring, and to administer a shock to stop it. The ICD may also be programmed to send a rapid burst of paced beats to interrupt the ventricular tachycardia. You may need to take anti-arrhythmic drugs to prevent repeated firing of the ICD.

• Expectations (prognosis)

  The outcome depends on the heart condition and symptoms.

• Complications

  Ventricular tachycardia may not cause symptoms in some people. However, it may be lethal in other people. It is a major cause of sudden cardiac death.

• Calling your health care provider

  Go to the emergency room or call the local emergency number (such as 911) if you have a rapid, irregular pulse, faint, or have chest pain. All of these may be signs of ventricular tachycardia.

• Prevention

  In some cases, the disorder is not preventable. In other cases, it can be prevented by treating heart diseases and correcting blood chemistries.

• References

  Olgin JE, Zipes DP. Specific Arrhythmias: Diagnosis and Treatment. In: Libby P, Bonow RO, Mann DL, Zipes DP. Libby: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 35.

Review Date: 5/15/2008

Reviewed By: Alan Berger, MD, Assistant Professor, Divisions of Cardiology and Epidemiology, University of Minnesota, Minneapolis, MN. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.